Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 451

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 1B
Chunk 451
---
  
     -  
     399,175 

    Timothy J. Lorber CFO* 
    2024 
     97,641  
     -  
     100,000  
     -  
     -  
     -  
     -  
     197,641 

    2023 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     - 

    Michael Vander Hoek, VP, CFO* 
    2024 
     228,008  
     -  
     41,840  
     -  
     -  
     -  
     -  
     269,848 

    2023 
     230,530  
     72,000  
        
     -  
     -  
     -  
     -  
     302,530 

    Peter Dritschilo, President and COO 
    2024 
     236,000  
     -  
     -  
     -  
     -  
     -  
     -  
     236,000 

    2023 
     242,012  
     72,000  
        
     -  
     -  
     -  
     -  
     314,012 

    Tyvin Rich, Chief Medical Officer 
    2024 
     218,000  
     -  
     -  
     -  
     -  
     -  
     -  
     218,000 

    2023 
     220,226  
     43,000  
     -  
     -  
     -  
     -  
     -  
     263,226 

*
Michael Vander Hoek served as CFO through June 12, 2024, at which time Timothy Lorber assumed the position of CFO on a part-time basis
commencing June 13, 2024 and became full-time CFO on September 9, 2024.

Employment
Agreements